This Just In
A new category of drugs called luteinising-hormone-releasing hormone (LHRH) agonists (say that ten times fast) are effective treatment for premenopausal women with estrogen receptive breast cancer according to a report in the UK medical journal, The Lancet.
Read the news story here; meanwhile, here’s a quote from The Lancet: “LHRH agonists provide an additional class of agents for treatment of premenopausal women with hormone-receptor-positive breast cancer.”
I’ve been saying for a while now that there were few adjuvant therapy options for premenopausal women — and that more research needed to be conducted in that area. Apparently I wasn’t the only one that felt that way. Way to go all.
As I learn more about this one, I’ll get you more information.
Many thanks to Erinn over at Parenting our Children … I appreciate the fact you forwarded me that link!



Leave a Reply